-- CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:
Charles River (CRL) delivered Q1 2026 revenue of $995.8M (+1.2% Y/Y, -1.5% organic), beating the $994M consensus, while adjusted EPS of $2.06 (-12.0% Y/Y) exceeded the $1.94 consensus view. Research Models and Services faced headwinds with organic revenue declining 5.5% to $208.4M and operating margin compressing 240 bps to 24.7%, while Discovery and Safety Assessment revenue was flat at $596.9M with margin pressure of 290 bps to 21.0%. CRL successfully completed strategic divestitures of its CDMO and Cell Solutions businesses on May 6, with additional European Discovery Services site sales expected this month. Management maintained yearly guidance for organic sales growth and adjusted EPS despite less favorable FX expectations. Manufacturing Solutions showed resilience with revenue of $190.5M (+2.9% organic) and operating margin improving 280 bps to 25.9% from restructuring cost savings. The company returned $200M to shareholders through repurchases, leaving $800M remaining in authorization.